Ovarian Carcinosarcoma — Trials

Ovarian Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 8%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03651206	Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib(ROCSAN)	recruiting	Phase 2 / Phase 3	138	ARCAGY/ GINECO GROUPOTHER	3	Sep 9, 2026	clinicaltrials
NCT06580314	Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer	recruiting	Phase 3	880	NRG OncologyOTHER	3	Aug 7, 2026	clinicaltrials